Dr. Karolina Edlund

Scientific staff

Head of department
Prof. Dr. Jan G. Hengstler
Secretariat
Monika Turajski
Address
Ardeystr. 67
44139 Dortmund

Here you will find the Publications from 2010 onwards that were produced at IfADo.

Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol 63: 934-942 (2015)
Gelsolin is associated with longer metastasis-free survival and reduced cell migration in estrogen receptor-positive breast cancer. Anticancer Res 35: 5277-5285 (2015)
The human endometrium-specific proteome defined by transcriptomics and antibody-based profiling. OMICS 19: 659-668 (2015)
Identification of sample annotation errors in gene expression datasets. Arch Toxicol 89: 2265-2272 (2015)
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer. Clin Cancer Res 20: 4660-4672 (2014)
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13: 397-406 (2014)
The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling. FASEB J 28: 5184-5196 (2014)
The human liver-specific proteome defined by transcriptomics and antibody-based profiling. FASEB J 28: 2901-2914 (2014)
Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression. Cancer Lett 356: 837-845 (2014)
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer 135: 2206-2214 (2014)
Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J Proteome Res 13: 5106-5119 (2014)
Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One 9(10): e111306 (2014) (9 pp)
The kidney transcriptome and proteome defined by transcriptomics and antibody-based profiling. PLoS One 9(12): e116125 (2014)
The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues. PLoS One 9(12): e115911 (2014)
1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer. BMC Cancer 14: 872 (2014) (9 pp)